Lv1
40 积分 2021-07-30 加入
Zolbetuximab plus mFOLFOX6 in patients with CLDN18.2-positive, HER2-negative, untreated, locally advanced unresectable or metastatic gastric or gastro-oesophageal junction adenocarcinoma (SPOTLIGHT): a multicentre, randomised, double-blind, phase 3 trial
6天前
已完结
A Modified Technique for Inducing Polycystic Ovary Syndrome in Mice
4个月前
已完结
Portable smartphone-enabled dydrogesterone sensors based on biomimetic polymers for personalized gynecological care
7个月前
已完结
Zolbetuximab plus mFOLFOX6 in patients with CLDN18.2-positive, HER2-negative, untreated, locally advanced unresectable or metastatic gastric or gastro-oesophageal junction adenocarcinoma (SPOTLIGHT): a multicentre, randomised, double-blind, phase 3 trial
7个月前
已完结
Osimertinib after Chemoradiotherapy in Stage III EGFR -Mutated NSCLC
8个月前
已完结
γ-Linolenic acid in maternal milk drives cardiac metabolic maturation
1年前
已完结
The Diagnostic and Prognostic Value of LIMK1/2: A Pan-Cancer Analysis
2年前
已完结
Rab27a and Rab27b control different steps of the exosome secretion pathway
2年前
已完结
Adebrelimab or placebo plus carboplatin and etoposide as first-line treatment for extensive-stage small-cell lung cancer (CAPSTONE-1): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
2年前
已完结
MiR-690 treatment causes decreased fibrosis and steatosis and restores specific Kupffer cell functions in NASH
2年前
已完结
皖公网安备34019202002308
